Work

Hypoxia — inducible factor prolyl hydroxylase inhibitors (HIF-PHI) — a breakthrough in treatment of anemia in patients with chronic kidney disease?

Year: 2020

Type: article

Source: Renal Disease and Transplantation Forum

Authors: Łukasz Jankowski, Magdalena Durlik

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3091255725

FWCI:

Cites:

Cited by:

Related to: 10